This 3-day forum is the “must attend” event for those senior decision-makers looking to drive their medical affairs teams and departments and enhance their KOL & stakeholder engagement at all levels.

The first day will feature several keynote presentations from VP-Level thought leaders on shaping and leading the medical affairs departments, justifying medical affairs performance through innovative metrics and tracking effectiveness of the function as an essential element of today’s pharmaceutical companies. They will be discussing the strategic drivers for medical affairs, and guidance on how to make best use of this vital function.

Day 2 of the Forum will feature 2 specific streams depending on your specific needs:

Stream 1: Enhancing Medical Communications for Medical Affairs – Medical Affairs departments are increasingly looking to implement next generation medical communication practices, to offer essential evidence-based information to stakeholders on demand, through a variety of classical, yet also increasingly digital channels. This stream will focus on two key aspects of medical communication. Firstly, issues such as: protocol writing for internal late-phase studies and research initiatives; working with External Experts (KOLs) to enhance publications, abstracts & posters and receiving proposals for investigator-initiated studies. The second section of this day will focus on Medical Scientific Marketing communications, including the review process, compliance issues, ensuring the claims made by marketing colleagues are justified and appropriately communicated and also effectively localized from global-level to country-level market requirements.

Stream 2: Real-World Evidence Generation for Medical Affairs – Generating real world evidence via observational studies and the use of patient registries is one of the fastest growing areas of pharmaceutical R&D. Such post-marketing studies are becoming increasingly important as regulatory agencies and payers demand more long-term data which demonstrates efficacy, safety and quality. The Medical Affairs unit plays a decisive role in generating this vital evidence and this stream will present solutions to the challenges companies face in generating high-quality evidence which will communicate a compelling value argument to all necessary stakeholders requirements.

Day 3: MedAffairs: MedTech

This session focuses on the fast-evolving role of medical affairs specifically for MedTech companies and the increasingly important need for this function which facilitates overall corporate performance. The different business model of MedTech vs Pharma, necessitates an adjustment in the way KOLs, external experts & patients are engaged with and communicated to. This highly-popular, 1-day stream is back and with new speakers, will enable the MedTech community to get the most out of their medical affairs teams and develop a more patient-centric business model.

Along with our exclusive networking dinner for all participants, the event will feature excellent networking opportunities and the chance to strengthen your contacts within the Medical Affairs community. The 2017 event was a sell-out so please make sure you book early to avoid disappointment.

Request agenda here for complete speaker list

Pharma & Biotech Industry Experts

Head of Global Medical Affairs Excellence
GSK, UK

Vice President, Medical Affairs
Norgine

Director Medical Affairs - Global Med. Strategic Acute Care,
MSD, Switzerland

Head of Medical Affairs & Patient Advocacy
Ultragenyx, Switzerland

Former VP Strategic Planning and Digital Practices
GSK, UK

Senior Manager Scientific Communications
Amgen, Germany

Head of Medical Affairs
Nordic Nanovector, Switzerland

Global Digital Marketing Lead
Norgine BV, Netherlands

Associate Director Medical Affairs, Russia & Eurasia
Teva, Russia

Head Medical Affairs
Biogen, Switzerland

President
PrecisionMedicine4Me, UK

 

MedTech Industry Experts

Director, Medical & Scientific Affairs
Boston Scientific, USA

Chief Medical Officer & Head of Market Access
Molnlycke Health Care, Sweden

Vice President, Head Global Clinical Strategy
Smith & Nephew, Switzerland

Director Medical Affairs MITG Europe, Middle East and Africa
Medtronic, Germany

Global Director Scientific Communications | Medical Affairs
Medtronic, France

Medical Affairs Manager EP, Europe
Boston Scientific, Germany

Medical Affairs Manager, EMEA
Alcon, Switzerland

 

Patients & Stakeholders

Head of Research and Development, St Andrew's Healthcare
Committee for Advanced Therapies, Member, EMA, UK

Founder
Patient Information Forum, UK

President and Patient Advocate
Inspire2Live, Netherlands

Patient Advocate
European AIDS Treatment Group (EATG), Switzerland

Writer, Patient Empowerment Network
Director, Health Care Social Media Monitor, Ireland

CEO
Tonic App, Portugal

Director of Digital Engagement and Communications
The Brain Tumour Charity, UK

Digital Communication Manager
Geneva University Hospitals, Switzerland

Founder & CEO
aparito, UK

Commercial Director
HealthUnlocked, UK

 

Expert Solution Providers

Director of Scientific Services
Complete HealthVizion

Business Development Director
Complete HealthVizion

Principal, Real-World & Late Phase
Syneos Health

Chief Medical Officer, Director of Real World Evidence and Health Economics
LINK Medical Research, Norway

Louise Carrington
Client Partnerships Lead,
Succinct Medical Communications

Partner
McKinsey & Company, Switzerland

Senior Digital Communications Lead
Succinct Medical Communications

Dr. Marc Pignot
Director Real World Research Consulting
Kantar Health, Germany

Partnership Manager
pH Associates, UK

Senior Director, Medical Affairs Strategic Solutions
Medscape

CEO
Within3

CEO, Head of Clinical Services, Senior Executive Coach
Pinnacle Wellbeing 247

 

 

 

Request agenda here for complete speaker list

Pictures from recent MedAffairs Leaders Forums. Imagine being there...

The first day will feature several keynote presentations from VP-Level thought leaders on shaping and leading the medical affairs departments, justifying medical affairs performance through innovative metrics and tracking effectiveness of the function as an essential element of today’s pharmaceutical companies. They will be discussing the strategic drivers for medical affairs, and guidance on how to make best use of this vital function.

SPEAKER LIST - DAY 1

Head of Global Medical Affairs Excellence
GSK, UK

Head of Medical Affairs
Nordic Nanovector, Switzerland

Head of Medical Affairs & Patient Advocacy
Ultragenyx, Switzerland

President
PrecisionMedicine4Me, UK

CEO
Within3

Head of Research and Development, St Andrew's Healthcare
Committee for Advanced Therapies, Member, EMA, UK

Founder
Patient Information Forum, UK

President and Patient Advocate
Inspire2Live, Netherlands

Patient Advocate
European AIDS Treatment Group (EATG), Switzerland

Writer, Patient Empowerment Network
Director, Health Care Social Media Monitor, Ireland

Partner
McKinsey & Company, Switzerland

Medical Affairs departments are increasingly looking to implement next generation medical communication practices, to offer essential evidence-based information to stakeholders on demand, through a variety of classical, yet also increasingly digital channels. This stream will focus on two key aspects of medical communication. Firstly, issues such as: protocol writing for internal late-phase studies and research initiatives; working with External Experts (KOLs) to enhance publications, abstracts & posters and receiving proposals for investigator-initiated studies. The second section of this day will focus on Medical Scientific Marketing communications, including the review process, compliance issues, ensuring the claims made by marketing colleagues are justified and appropriately communicated and also effectively localized from global-level to country-level market requirements.

SPEAKER LIST - DAY 2 - STREAM 1

Former VP Strategic Planning and Digital Practices
GSK, UK

Senior Manager Scientific Communications
Amgen, Germany

Director of Scientific Services
Complete HealthVizion

Business Development Director
Complete HealthVizion

Head Medical Affairs
Biogen, Switzerland

Senior Digital Communications Lead
Succinct Medical Communications

Global Digital Marketing Lead
Norgine BV, Netherlands

Senior Director, Medical Affairs Strategic Solutions
Medscape

CEO
Tonic App, Portugal

Director of Digital Engagement and Communications
The Brain Tumour Charity, UK

Digital Communication Manager
Geneva University Hospitals, Switzerland

Associate Director Medical Affairs, Russia & Eurasia
Teva, Russia

 

 

 

 

Generating real world evidence via observational studies and the use of patient registries is one of the fastest growing areas of pharmaceutical R&D. Such post-marketing studies are becoming increasingly important as regulatory agencies and payers demand more long-term data which demonstrates efficacy, safety and quality. The Medical Affairs unit plays a decisive role in generating this vital evidence and this stream will present solutions to the challenges companies face in generating high-quality evidence which will communicate a compelling value argument to all necessary stakeholders requirements.

SPEAKER LIST - DAY 2 - STREAM 2

Founder & CEO
aparito, UK

Commercial Director
HealthUnlocked, UK

Director Medical Affairs - Global Med. Strategic Acute Care,
MSD, Switzerland

Principal, Real-World & Late Phase
Syneos Health

Chief Medical Officer, Director of Real World Evidence and Health Economics
LINK Medical Research, Norway

Vice President, Medical Affairs
Norgine

Medical Affairs Manager, EMEA
Alcon, Switzerland

Director Real World Research Consulting
Kantar Health, France

 

 

 

This session focuses on the fast-evolving role of Medical Affairs specifically for MedTech companies and the increasingly important need for this function which facilitates overall corporate performance. The different business model of MedTech vs Pharma, necessitates an adjustment in the way KOLs, external experts & patients are engaged with and communicated to. This highly-popular, 1-day stream is back and with new speakers, will enable the MedTech community to get the most out of their Medical Affairs teams and develop a more patient-centric business model.

SPEAKER LIST - DAY 3

Vice President, Medical Affairs
Norgine

CEO, Head of Clinical Services, Senior Executive Coach
Pinnacle Wellbeing 24

Director, Medical & Scientific Affairs
Boston Scientific, USA

Chief Medical Officer & Head of Market Access
Molnlycke Health Care, Sweden

Vice President, Head Global Clinical Strategy
Smith & Nephew, Switzerland

Director Medical Affairs MITG Europe, Middle East and Africa
Medtronic, Germany

Global Director Scientific Communications | Medical Affairs
Medtronic, France

Medical Affairs Manager EP, Europe
Boston Scientific, Germany

 

This one-day workshop will take participants through the medical communications planning and delivery process step-by-step. We will present theory and best practice around a number of aspects of communications planning and programme development, and focus on how digital tools and tactics can best be implemented in medical communications. At each stage, participants will then work together on an example scenario to discuss and develop their own ideas with support from our experts. There will be plenty of opportunity for questions and discussion.

Please note: This workshop is included in the 3 day registration package. Please contact your NextLevel representative if you’d like to upgrade your 2 day attendance to include this workshop.

Your experienced workshop leaders

Louise Carrington,
Client Partnerships Lead,
Succinct Medical Communications

Senior Digital Communications Director,
Succinct Medical Communications

PHARMA & MEDICAL DEVICE: VPs, Directors & Managers of:

Customer Relations, Medical Affairs, Medical Science Liaisons, Medical Education, Health Outcomes & Liaison, Medical Communications, Marketing, KOL & Stakeholder Engagement, Late Phase & Real-World Research, Scientific Affairs, Medical Advisors and Patient-Centricity.

Event Partners

Event Educational Partner

Media Partners

Related Podcast

This event is accredited for CPD (Continuing Professional Development) status

RECEIVE DISCOUNTED FLIGHTS WHEN YOU REGISTER FOR THIS EVENT WITH

Share with Colleagues